---

---

tags : Research    symbols : Sny   

save search

---

Quebec's INESSS recommends BEYFORTUS for the prevention of RSV for all infants 8 months of age and younger(1)
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 0.0% | O: 0.0% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -1.81% | O: -1.81% H: 0.0% C: 0.0%
beyfortus for rsv

---

Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -0.22% | O: -0.53% H: 0.61% C: 0.61%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -2.2% | O: -0.04% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 0.52% | O: 0.13% H: 0.11% C: -1.73%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -1.01% | O: 1.95% H: 0.0% C: 0.0%
research global gastrointestinal therapeutics

---

MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions 
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
MLTX | $42.19 -0.14% -0.14% 530K |

| -7.25% | O: -2.03% H: 2.45% C: 0.48%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.25% | O: -0.32% H: 0.0% C: 0.0%
partnership health research technology skin

---

The Global Probiotics Market Forecasted to Flourish as Wellness Trends Gain Momentum, the Market to Hit $115.07 Billion - Focus Research Report by Arizton
Published: 2024-04-09 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
CVS | $69.75 1.49% 0.13% 7.8M |

Retail Trade

| -5.9% | O: -0.35% H: 0.11% C: -2.67%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.25% | O: -0.32% H: 0.0% C: 0.0%
report research global wellness trends market

---

Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| Email alert Add to watchlist
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| Email alert Add to watchlist
GMAB | $28.72 1.38% 1.36% 360K |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| Email alert Add to watchlist
GNMSF | $290.38 3.83% 220 |

Health Technology

| Email alert Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| Email alert Add to watchlist
research global leukemia therapeutics market

---

United States Self-Monitoring Blood Glucose Devices Market Research 2023-2032: SMBG Devices and CGM Systems Surge - The Shift from Traditional Blood Glucose Meters
Published: 2024-03-28 (Crawled : 02:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -7.02% | O: -1.17% H: 0.0% C: -0.89%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -8.47% | O: -0.96% H: 0.0% C: 0.0%
blood research market

---

Biond Biologics Announces Presentation of BND-35, a Novel Anti-ILT3 Antibody for Remodeling the Tumor Microenvironment, at the American Association for Cancer Research (AACR) 2024 Annual Meeting
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.72% | O: 1.93% H: 0.0% C: 0.0%
bnd-35 antibody association presentation cancer tumor research meeting

---

World Cancer Immunotherapy Market Research 2023-2027: Curing Cancer is Generating Enormous New Opportunities - Outcome Potential, Technology Environment, Target Solutions
Published: 2024-03-16 (Crawled : 04:20) - prnewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
world cancer research solutions immunotherapy technology market

---

Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
Published: 2024-03-13 (Crawled : 01:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -4.76% | O: -0.23% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -6.71% | O: -0.07% H: 0.09% C: -0.7%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -10.2% | O: 0.66% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -0.55% | O: 0.27% H: 0.5% C: 0.11%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -8.97% | O: 0.59% H: 0.01% C: -1.45%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.85% | O: -0.04% H: 0.0% C: 0.0%
report research global

---

World Vaccine Market Research Report 2023-2024 and 2030 - Increasing Consumer Awareness Towards Immunization Fueling Growth Amid Growing Prevalence of Infectious Diseases
Published: 2024-03-12 (Crawled : 02:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.84% | O: 0.01% H: 0.0% C: 0.0%
report vaccine world research growing growth market

---

Vaccine research market size to grow at a CAGR of 9.88% from 2022 to 2027, Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players, Technavio
Published: 2024-03-11 (Crawled : 14:30) - prnewswire.com
CMXHF | $172.54 -19.21% 50 |

n/a

| -5.41% | O: 0.41% H: 0.0% C: 0.0%
CSLLY | $86.918 3.3% 60K |

n/a

| -6.8% | O: -4.92% H: 3.76% C: 3.44%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -5.92% | O: -3.4% H: 1.49% C: 1.49%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 3.19% | O: 1.55% H: 0.82% C: 0.16%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -12.05% | O: -1.41% H: 5.06% C: 4.01%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -8.21% | O: -0.6% H: 0.19% C: 0.09%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -11.91% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.31% | O: 0.57% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 2.65% | O: 1.08% H: 0.82% C: 0.67%
pharma vaccine astrazeneca research key market

---

Net Zero Strategies in the Media Sector: 2024 Thematic Research Report - 15/20 Companies Analyzed have Set Either a Short or Long-term Target to Reduce their Emissions
Published: 2024-03-08 (Crawled : 10:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.38% | O: -0.08% H: 0.0% C: 0.0%
FOXA | News | $31.38 1.98% 1.94% 2.3M |

Consumer Services

| 6.39% | O: 0.17% H: 0.98% C: 0.52%
FOX | News | $28.87 2.05% 2.01% 1.1M |

Consumer Services

| 7.35% | O: 0.19% H: 0.99% C: 0.61%
media companies report research set

---

2024 Tech M&A Regulation Thematic Research Report | Now Available
Published: 2024-03-08 (Crawled : 05:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.38% | O: -0.08% H: 0.0% C: 0.0%
report research

---

Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma
Published: 2024-03-06 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.01% | O: 0.0% H: 0.8% C: 0.8%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.29% | O: -0.45% H: 0.0% C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K |

Health Technology

| -8.56% | O: 0.78% H: 1.93% C: 0.97%
iph6501 first study

---

Alnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care Antihypertensives
Published: 2024-03-05 (Crawled : 16:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -3.17% | O: 1.17% H: 0.0% C: 0.0%
ALNY | $144.315 -0.58% -0.59% 700K |

Health Technology

| -3.25% | O: -0.73% H: 1.52% C: 0.5%
positive blood care topline results study

---

Pharmaceutical Industry Research Highlights Sustainability and Growth Opportunities Through 6P Framework Implementation
Published: 2024-02-27 (Crawled : 02:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -10.38% | O: -1.07% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.76% | O: -0.94% H: 0.0% C: 0.0%
research growth

---

Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-‘574) Antibody at the 2024 ECCO Annual Meeting
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 0.38% | O: 2.72% H: 0.0% C: -0.8%
TEVA | $12.86 0.63% 0.0% 10M |

Health Technology

| 1.23% | O: 1.31% H: 0.67% C: -0.91%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -1.56% | O: 2.53% H: 0.0% C: 0.0%
antibody meeting teva

---

Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round to $147M
Published: 2024-02-13 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -7.44% | O: 0.7% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -1.49% | O: -0.06% H: 0.0% C: 0.0%
series total

---

Antithrombotic/Anticoagulant Drugs Market Forecasted to Surge to $46.2 Billion by 2028: BCC Research
Published: 2024-02-12 (Crawled : 15:30) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -7.06% | O: 0.41% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -2.34% | O: -0.86% H: 0.0% C: 0.0%
research market

---

Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published: 2024-02-09 (Crawled : 10:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K |

Health Technology

| -12.38% | O: -0.91% H: 3.88% C: 3.88%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 8.24% | O: -2.6% H: 2.26% C: 1.44%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -9.35% | O: -2.46% H: 0.0% C: 0.0%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -12.95% | O: 4.66% H: 0.0% C: -3.92%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -7.8% | O: -0.04% H: 0.11% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -8.17% | O: -0.37% H: 0.21% C: 0.05%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -5.31% | O: 0.33% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -1.26% | O: 1.11% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 7.47% | O: -1.28% H: 1.05% C: -0.72%
research global market

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---